latest news on glp 1 drugs A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD Professor Receives Grant to Study

Lavillette D

Time-varying weight change since discontinuation was included to consider the potential association with outcomes of weight regain since the GLP-1 RA was stopped

Gastrointestinal Disease Since cobalaminIF complex receptors are located in the ileum, chronic gastrointestinal disease, alimentary lymphoma, and ileum resection can lead to cobalamin deficiency, as these conditions reduce ileum absorption capacity [35]

Four-weeks daily intake of oral collagen hydrolysate results in improved skin elasticity, especially in sun-exposed areas: a randomized, double-blind, placebo-controlled trial

Current data shows that approximately 4-5% of adults in developed nations now use these medications, representing a significant shift in how healthcare approaches chronic weight management

doi: 10.1001/jamasurg.2016.2317 5 Sanchez-GarridoMABrandtSJClemmensenCMullerTDDiMarchiRDTschopMH